0001144204-18-035852.txt : 20180626 0001144204-18-035852.hdr.sgml : 20180626 20180626165442 ACCESSION NUMBER: 0001144204-18-035852 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180625 FILED AS OF DATE: 20180626 DATE AS OF CHANGE: 20180626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chiesi Ventures, Inc. CENTRAL INDEX KEY: 0001744577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38542 FILM NUMBER: 18919803 BUSINESS ADDRESS: STREET 1: P.O. BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 110287 BUSINESS PHONE: 919-998-3300 MAIL ADDRESS: STREET 1: P.O. BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 110287 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chiesi Ventures, LP CENTRAL INDEX KEY: 0001744641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38542 FILM NUMBER: 18919804 BUSINESS ADDRESS: STREET 1: P.O. BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 110287 BUSINESS PHONE: 919-998-3300 MAIL ADDRESS: STREET 1: P.O. BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 110287 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chiesi Giacomo CENTRAL INDEX KEY: 0001744492 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38542 FILM NUMBER: 18919805 MAIL ADDRESS: STREET 1: P.O. BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 110287 FORMER NAME: FORMER CONFORMED NAME: Chiesi Giancomo DATE OF NAME CHANGE: 20180622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kezar Life Sciences, Inc. CENTRAL INDEX KEY: 0001645666 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473366145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-822-5600 MAIL ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tv497342_form4.xml FORM 4 X0306 4 2018-06-25 1 0001645666 Kezar Life Sciences, Inc. KZR 0001744577 Chiesi Ventures, Inc. P.O. BOX 110287 RESEARCH TRIANGLE PARK NC 27709 0 0 1 0 0001744641 Chiesi Ventures, LP P.O. BOX 110287 RESEARCH TRIANGLE PARK NC 27709 0 0 1 0 0001744492 Chiesi Giacomo P.O. BOX 110287 RESEARCH TRIANGLE PARK NC 27709 0 0 1 0 Common Stock, par value $0.001 per share 2018-06-25 4 C 0 314819 A 314819 I See footnote Series B Preferred Stock, par value $0.001 per share 2018-06-25 4 C 0 314819 0 A Common Stock 314819 0 I See footnote The Series B Preferred Stock, par value $0.001 per share, converted into Common Stock, par value $0.001 per share, on a one-for-one basis and had no expiration date. These shares are held of record by Chiesi Ventures, LP ("Chiesi Ventures"). Chiesi Ventures, Inc. ("Chiesi") is the general partner of Chiesi Ventures, and Mr. Giacomo Chiesi is President of, and may be deemed to have control of, Chiesi. By virtue of their respectively relationships with Chiesi Ventures, each of Chiesi and Mr. Chiesi may be deemed to indirectly beneficially own the shares of which Chiesi Ventures is the record owner. Each of Chiesi and Mr. Chiesi disclaims beneficial ownership of the shares reported herein, except to the extent of its or his respective pecuniary interests therein. This report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. /s/ Amanda Keister, attorney-in-fact for Chiesi Ventures, LP 2018-06-26 /s/ Amanda Keister, attorney-in-fact for Chiesi Ventures, Inc. 2018-06-26 /s/ Amanda Keister, attorney-in-fact for Giacomo Chiesi 2018-06-26